CD177 and cancer: Consequently, further understanding of the biochemical and biomechanical mechanisms, in particular epithelial-to-mesenchymal transition (EMT) and interactions of matrix substrates with integrins and other cell-surface receptors, that drive the interplay between cancer cells and tumor stroma during cancer progression will be of strategic relevance toward cancer prevention and drug treatment development.